IDXX Q3 2022 Earnings — IDEXX Laboratories, Inc. Revenue & Financial Results | Market Cap Arena

IDXXIDEXX Laboratories, Inc.

$48B

Q3 2022 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$842M+3.9% YoY

Gross Profit

$507M60.2% margin

Operating Income

$245M29.1% margin

Net Income

$181M21.5% margin

EPS (Diluted)

$2.15

QoQ Revenue Growth

-2.2%

Cash Flow

Operating Cash Flow

$189M

Free Cash Flow

$151M

Stock-Based Comp.

$13M

Balance Sheet

Total Assets

$2.6B

Total Liabilities

$2.2B

Stockholders' Equity

$476M

Cash & Equivalents

$99M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$842M	$810M	+3.9%
Gross Profit	$507M	$473M	+7.1%
Operating Income	$245M	$226M	+8.3%
Net Income	$181M	$175M	+3.3%

Revenue Segments

Up Front Customer Loyalty Programs And Volume Commitment Programs

$3.0B98%

Reagent Rental Programs

$36M1%

Extended Warranties And Post Contract Support

$12M0%

Instrument Rebate Programs

$3M0%

Geographic Segments

UNITED STATES

$560M67%

EMEA

$152M18%

Asia Pacific

$77M9%

CANADA

$34M4%

Latin America

$19M2%